Northern Trust Corp Centogene N.V. Transaction History

Northern Trust Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.3 - $5.44 $44,371 - $73,146	-13,446 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$4.56 - $10.56 $752 - $1,742	-165 Reduced 1.21%	13,446 $70,000
Q3 2021 Nov 15, 2021	BUY	$9.9 - $11.72 $920 - $1,089	93 Added 0.69%	13,611 $150,000
Q2 2021 Aug 13, 2021	SELL	$9.02 - $12.93 $687,305 - $985,240	-76,198 Reduced 84.93%	13,518 $141,000
Q1 2021 May 12, 2021	SELL	$10.56 - $13.94 $175,454 - $231,613	-16,615 Reduced 15.63%	89,716 $1.09 Million

Q4 2020 Feb 11, 2021	SELL	$9.44 - $13.3 $15,717 - $22,144	-1,665 Reduced 1.54%	106,331 $1.15 Million
Q3 2020 Nov 16, 2020	BUY	$9.3 - $25.16 $533,308 - $1.44 Million	57,345 Added 113.22%	107,996 $1.02 Million
Q2 2020 Aug 14, 2020	BUY	$15.99 - $22.88 $405,522 - $580,259	25,361 Added 100.28%	50,651 $1.16 Million
Q1 2020 May 14, 2020	BUY	$9.76 - $23.8 $123,395 - $300,903	12,643 Added 99.97%	25,290 $505,000
Q4 2019 Feb 14, 2020	BUY	$8.1 - $14.6 $102,440 - $184,646	12,647 New	12,647 $127,000

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.